Priemer hodnotení spoločnosti 180 Life Sciences
Aká je hodnota metriky Priemer hodnotení spoločnosti 180 Life Sciences?
Hodnota metriky Priemer hodnotení spoločnosti 180 Life Sciences Corp. je 2.50
Aká je definícia metriky Priemer hodnotení?
Priemer hodnotení (Recommendation mean) je priemer hodnotení analytikov akcií spoločnosti, ktorý sa pohybuje medzi 1.0 (rozhodne kúpiť) a 5.0 (rozhodne predať).
Mean of recommendations is an average of ratings from different analysts but it should still be used with other research and investment metrics in order to make investment decisions. It is important to understand a firm's entire scale when assimilating ratings. Additionally, analyst recommendations on stocks owned by firms employing them may be seen as potentially biased.
Financial analysts are often employed by mutual and pension funds, hedge funds, securities firms, banks, investment banks, insurance companies, and other businesses, helping these companies or their clients make investment decisions. Financial analysts employed in commercial lending perform "balance sheet analysis," examining the audited financial statements and corollary data in order to assess lending risks. In a stock brokerage house or in an investment bank, they read company financial statements and analyze commodity prices, sales, costs, expenses, and tax rates in order to determine a company's value and project future earnings. In any of these various institutions, the analyst often meets with company officials to gain a better insight into a company's prospects and to determine the company's managerial effectiveness.
Usually, financial analysts study an entire industry, assessing current trends in business practices, products, and industry competition. They must keep abreast of new regulations or policies that may affect the industry, as well as monitor the economy to determine its effect on earnings.
Priemer hodnotení spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou 180 Life Sciences
Čomu sa venuje spoločnosť 180 Life Sciences?
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
Firmy s metrikou priemer hodnotení podobnou spoločnosti 180 Life Sciences
- Hodnota metriky Priemer hodnotení spoločnosti Revvity je 2.47
- Hodnota metriky Priemer hodnotení spoločnosti Cardinal Health je 2.47
- Hodnota metriky Priemer hodnotení spoločnosti Cintas je 2.47
- Hodnota metriky Priemer hodnotení spoločnosti Textron je 2.47
- Hodnota metriky Priemer hodnotení spoločnosti Ralph Lauren Corp je 2.48
- Hodnota metriky Priemer hodnotení spoločnosti NOV Inc je 2.48
- Hodnota metriky Priemer hodnotení spoločnosti 180 Life Sciences je 2.50
- Hodnota metriky Priemer hodnotení spoločnosti Landbridge je 2.52
- Hodnota metriky Priemer hodnotení spoločnosti Urban Outfitters je 2.52
- Hodnota metriky Priemer hodnotení spoločnosti Wells Fargo & Co je 2.52
- Hodnota metriky Priemer hodnotení spoločnosti United Airlines Inc je 2.52
- Hodnota metriky Priemer hodnotení spoločnosti Cognizant Technology Solutions je 2.52
- Hodnota metriky Priemer hodnotení spoločnosti Grupo Aeroportuario Del Pacifico SAB de CV je 2.53